Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Recruiting
Phase 4
Interventional Study
Obesity
Chronic Kidney Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 60 (estimated)
- Sponsor
- Western University, Canada · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* BMI; 35 kg/m\^2
* 10% risk of ESKD requiring renal replacement therapy over 2 years or receiving dialysis
Exclusion Criteria:
* Known contraindication to a GLP-1RA (pancreatitis, personal or family history of medullary thyroid cancer, hypersen…
Contacts